Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_2893642
Proper Citation: Leinco Technologies Cat# H1498, RRID:AB_2893642
Target Antigen: Fc (Gamma) Fragment Specific, IgG
Host Organism: donkey
Clonality: polyclonal secondary
Comments:
Info: Donkey Whole Molecule Anti-Human IgG, Fc (Gamma) Fragment Specific recognizes Human IgG, Fc (Gamma) Fragment Specific. This secondary antibody was purified using antigen affinity chromatography and has been adsorbed against serum proteins and immunoglobulins to minimize species cross-reactivity.
We found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Donkey Anti-Human IgG, Fcγ Fragment Specific (Adsorbed Against: Ms., Bv., Hs.) - DyLight® 650.
No alerts have been found for Donkey Anti-Human IgG, Fcγ Fragment Specific (Adsorbed Against: Ms., Bv., Hs.) - DyLight® 650.
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.